Skip to main content

Table 4 Linear relationship between the relative change of PT-INR and the difference in daptomycin concentrations between the trough and peak

From: Dose-dependent artificial prolongation of prothrombin time by interaction between daptomycin and test reagents in patients receiving warfarin: a prospective in vivo clinical study

Reagent

n

Unadjusted β (95% CI) (/μg/mL)

p value

r2

H0: β = 0

1

34

5.1 × 10−4 (−9.2 × 10−4–1.9 × 10−3)

0.48

0.02

2

34

2.2 × 10−3 (−5.6 × 10−4–4.9 × 10−3)

0.12

0.15

3

34

3.1 × 10−3 (2.3 × 10−5–6.3 × 10−3)

0.048

0.19

4

34

8.5 × 10−4 (−2.2 × 10−4–1.9 × 10−3)

0.12

0.08

5

32

−1.8 × 10−4 (−9.2 × 10−4–5.6 × 10−4)

0.62

0.006

6

33

4.3 × 10−4 (−7.3 × 10−4–1.6 × 10−3)

0.45

0.02

7

33

−5.0 × 10−5 (−2.0 × 10−3–1.9 × 10−3)

0.96

<0.001

8

34

−2.3 × 10−4 (−2.1 × 10−3–1.6 × 10−3)

0.80

0.003

9

34

2.3 × 10−4 (−1.1 × 10−3–1.6 × 10−3)

0.73

0.003